Source:http://linkedlifedata.com/resource/pubmed/id/20026799
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2010-1-29
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1527-7755
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
519-21
|
pubmed:meshHeading |
pubmed-meshheading:20026799-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20026799-Humans,
pubmed-meshheading:20026799-Lymph Node Excision,
pubmed-meshheading:20026799-Male,
pubmed-meshheading:20026799-Neoplasm Recurrence, Local,
pubmed-meshheading:20026799-Retroperitoneal Space,
pubmed-meshheading:20026799-Testicular Neoplasms
|
pubmed:year |
2010
|
pubmed:articleTitle |
Weighing risks and benefits of postchemotherapy retroperitoneal lymph node dissection: not so easy.
|
pubmed:publicationType |
Editorial,
Comment
|